
Venture capital · Early stage
Myelin
Myelin is a venture capital firm run by founders-turned-investors that backs early-stage startups across industries, from seed through Series A.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Myelin right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Myelin joined, from press and the firm’s own posts.
Every round Myelin joined
Round sizes, Myelin’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Myelin backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Myelin
Events where Myelin’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Myelin is based in Montevideo, Uruguay.
1 fund vehicle is on public registers (SEC adviser filings), including MYELIN II LIMITED PARTNERSHIP.
Stages: Seed, Series A. Sectors: Generalist. From the firm’s own website.
Myelin partners with outlier founders who have ideas for a future worth living in. It is sector-agnostic and invests early, drawing on its partners' own experience as founders. From the firm’s own website.
Myelin lists 56 portfolio companies on its website, including Aura Biosciences, Cookunity, Neurosity, Pipedream and Forta Health.
Firms whose websites list some of the same companies include Overwater Ventures -, CAUSATION VENTURES, L.L.C. and Great Oaks Venture Capital.
Know before Myelin’s next round is announced.
PRO tracks Myelin’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.